Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



AMSBIO Expand Range of FFPE Cancer Cell Line Controls

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications.
 

Read the rest of entry »

Evox Therapeutics has secured £655,000 in funding from Duchenne UK

Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.Duchenne is a highly debilitating, progressive, muscle-wasting disorder caused by the lack of functional dystrophin protein, for which there is currently no cure.

Read the rest of entry »

Abingdon Health launches App that transforms a Smartphone into a rapid analytical tool

13 November 2018: BioHub Birmingham® tenant Abingdon Health has launched an intuitive software application called AppDx. AppDx enables a Smartphone to ‘read’ lateral flow test lines, using the inbuilt camera, which translates the image into numerical data.  

Read the rest of entry »

Diamond Win Two Categories in the 2018 TOPRA Awards

Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards.

Read the rest of entry »

Absolute Antibody Opens New Facility to Support Continued Growth of its Recombinant Antibody Technology

Absolute Antibody specialises in recombinant antibody products and services. All of our manufacturing takes place in the UK, but over 70% of our revenue comes from international exports. This expansion will allow us to meet growing global demand for recombinant antibody technology across the pharmaceutical, diagnostics, and academic sectors.

Read the rest of entry »

Wickham Laboratories to Exhibit at Pharmig 2018

Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham.

This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry.

Read the rest of entry »

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park

Oxford, UK, 1 November 2018 - In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is expanding its Oxford presence to the new Schrödinger Building on The Oxford Science Park, one of the UK's leading parks for science and technology companies.

Read the rest of entry »

Wickham Laboratories article on the Preservative Efficacy Test (PET) and Challenges in Preventing Microbial Growth

Wickham Laboratories are excited to announce their latest article being published by Cleanroom Technology in November, “Testing Preservatives with PET”, written by Microbiology Business Support Coordinator, Tasmin Stock. The article discusses specific challenges we face when preventing microbial growth, considering the regulations & validations of drug products and why efficacy is the main concern in active ingredients.

Read the rest of entry »

New lab facility for life science companies to open on Newcastle Helix

The Biosphere will provide a home for ambitious companies within life sciences and innovation, research and development. The new 90,000 sq. ft purpose-built £25m facility will contain both commercial laboratory and office spaces. As well as satisfying commercial laboratory demand, a conferencing facility for up to 80 people will offer a space for an events programme and for the sector to meet and share knowledge. The building is due for completion late November 2018.

Read the rest of entry »

ERA Consulting Group and Hybrid Concepts International Announce Collaboration Agreement to Expand Strategic Cell & Gene Therapy Regulatory Services

The ERA Consulting Group (ERA) and Hybrid Concepts International (HCI) announced on 8 October that they have entered into a collaboration agreement in order to more efficiently and effectively support global clients in response to the growing global demand for strategic regulatory support for companies developing cell and gene therapy products, regenerative medicines, and other advanced therapies. 

Read the rest of entry »

Pages: Previous1234567...44NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.